Carlos Remédios

Carlos Remédios has a diverse work experience spanning over 20 years. Carlos currently holds the role of Regional Finance Lead at Ultragenyx, where they are responsible for overseeing all FP&A and controllership activities in the EMEA region. Carlos has also worked at Alnylam Pharmaceuticals, where they held various positions including Director Financial Planning & Analytics, Associate Director Business Financial Planning & Analysis, and Sr. Manager Business Planning & Analysis. Prior to that, Carlos worked at Biogen as a Business Planning Manager EU+ and Associate Finance Manager. Carlos started their career at Merck as a Finance Analyst and also served as a Finance Analyst at DHL. Throughout their career, Carlos has gained extensive experience in financial planning, analysis, and business partnering.

Carlos Remédios has a Master's degree in Finance, Enterprise Management & Control from ISCTE-INDEG, which they obtained between 2011 and 2014. Carlos also holds a University degree in Economics from Instituto Superior de Economia e Gestão, attained from 1997 to 2001. In addition, Carlos has a Master's degree in Finance from INDEG-ISCTE Executive Education, but the specific dates of completion are not provided. Carlos has also obtained a certification in Master Degree in Finance, but no information regarding the institution or the year of attainment is available. Carlos has also attended Citeforma, but no specific degree or field of study is mentioned.